Merogit 250 mg/vial (IV Injection or Infusion)
250 mg vial: ৳ 400.00
Medicine Details
Category | Details |
---|---|
Generic | Meropenem trihydrate |
Company | Ziska pharmaceuticals ltd |
Also available as |
Title
- Merogit Antibiotic Injection
Categories
- Pharmaceuticals
- Antibiotics
- Parenteral Medication
Description
- A broad-spectrum carbapenem antibiotic for intravenous administration
Indications
- Treatment of pneumonia
- Treatment of urinary tract infections
- Treatment of intra-abdominal infections
- Treatment of gynaecological infections
- Treatment of skin and skin structure infections
- Treatment of meningitis
- Treatment of septicaemia
- Treatment of pulmonary infections in cystic fibrosis
- Empiric treatment for presumed infections in patients with febrile neutropenia
Mode of action
- Bactericidal action by interfering with bacterial cell wall synthesis
- Potent bactericidal activity against a broad spectrum of Gram-positive and Gram-negative, aerobic and anaerobic bacteria
Dosage
- 500 mg to 1 gm by intravenous administration every 8 hours for adults
- 10 to 40 mg/kg intravenously every 8 hours for children (3 months to 12 years)
- Dosage and duration of therapy based on type, severity of infection, and the patient's condition
Administration
- Intravenous infusion over approximately 15-30 minutes
- Intravenous bolus (5 to 20 ml) over approximately 3-5 minutes
Interaction
- Competes with Probenecid for active tubular secretion
- May reduce serum valproic acid levels
Contraindications
- Hypersensitivity to Meropenem
Side effects
- Inflammation
- Thrombophlebitis
- Pain at the site of injection
- Skin reactions like rash, pruritus, urticaria
- Abdominal pain
- Nausea
- Vomiting
- Diarrhea
- Headache
Pregnancy lactation
- Pregnancy Category B
- Caution should be exercised when administered to nursing women
Precautions warnings
- Allergic reaction may require discontinuation of the drug and appropriate measures
- Use in patients with hepatic disease should be carefully monitored
Special populations
- Dosage adjustments in renal impairment (creatinine clearance < 51 ml/min)
- No dosage adjustments necessary in hepatic impairment
- No dosage adjustments necessary in elderly patients unless creatinine clearance is < 51 ml/min
- Efficacy and tolerability not established in infants under 3 months
Overdose effects
- Symptomatic treatment for accidental overdose
- Rapid renal elimination in normal individuals
- Hemodialysis for removal in subjects with renal impairment
Therapeutic class
- Carbapenem Antibiotic
Reconstitution
- Reconstitute with sterile water for injection
- Compatible with various infusion fluids
- Freshly reconstituted solution recommended
- Maintains potency for up to 3 hours at up to 25°C or 13 hours at up to 5°C
Storage conditions
- Store in a cool, dry place (below 30°C)
- Keep away from light and moisture
- Keep out of the reach of children
Related Brands
- Admero 1 gm/vial (IV Injection or Infusion) - ad-din-pharmaceuticals-ltd
- Admero 500 mg/vial (IV Injection or Infusion) - ad-din-pharmaceuticals-ltd
- Merocil 250 mg/vial (IV Injection or Infusion) - pharmacil-limited
- G-Meropenem 1 gm/vial (IV Injection or Infusion) - gonoshasthaya-pharma-ltd
- G-Meropenem 500 mg/vial (IV Injection or Infusion) - gonoshasthaya-pharma-ltd